Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks

If approved, deucrictibant will be the first oral bradykinin B2 receptor antagonist to treat HAE attacksNDA includes positive data from ...

Patch AM: Could San Diego’s odor-control spray be weakening La Jolla’s kelp forests?

Coming up on the San Diego Patch calendar: Kids | Sewing: Junior Designer's Nature Makers, 7-12yrs ...